The Roles of Dopamine Transport Inhibition and Dopamine Release Facilitation in Wake Enhancement and Rebound Hypersomnolence Induced by Dopaminergic Agents

STUDY OBJECTIVE: Rebound hypersomnolence (RHS: increased sleep following increased wake) is a limiting side-effect of many wake-promoting agents. In particular, RHS in the first few hours following wake appears to be associated with dopamine (DA)-releasing agents, e.g., amphetamine, but whether it c...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Gruner, John A., Marcy, Val R., Lin, Yin-Guo, Bozyczko-Coyne, Donna, Marino, Michael J., Gasior, Maciej
פורמט: Artigo
שפה:Inglês
יצא לאור: Associated Professional Sleep Societies, LLC 2009
נושאים:
Dopamine Agents and Rebound Hypersomnolence
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768949/
https://ncbi.nlm.nih.gov/pubmed/19928382
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים